Bar-Or A - Search Results

1

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.

Bar-Or A, Freedman MS, Kremenchutzky M, Menguy-Vacheron F, Bauer D, Jodl S, Truffinet P, Benamor M, Chambers S, O'Connor PW. Bar-Or A, et al. Neurology. 2013 Aug 6;81(6):552-8. doi: 10.1212/WNL.0b013e31829e6fbf. Epub 2013 Jul 12. Neurology. 2013. PMID: 23851964 Free PMC article. Clinical Trial.

2

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, Pennington CJ, Bourgoin P, Edwards DR, Yong VW. Bar-Or A, et al. Brain. 2003 Dec;126(Pt 12):2738-49. doi: 10.1093/brain/awg285. Epub 2003 Sep 23. Brain. 2003. PMID: 14506071

3

Immunology of multiple sclerosis.

Bar-Or A. Bar-Or A. Neurol Clin. 2005 Feb;23(1):149-75, vii. doi: 10.1016/j.ncl.2004.11.001. Neurol Clin. 2005. PMID: 15661092 Review. No abstract available.

4

Human immune studies in multiple sclerosis.

Bar-Or A. Bar-Or A. Adv Neurol. 2006;98:91-109. Adv Neurol. 2006. PMID: 16400829 Review. No abstract available.

5

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.

O'Connor PW, Li D, Freedman MS, Bar-Or A, Rice GP, Confavreux C, Paty DW, Stewart JA, Scheyer R; Teriflunomide Multiple Sclerosis Trial Group; University of British Columbia MS/MRI Research Group. O'Connor PW, et al. Neurology. 2006 Mar 28;66(6):894-900. doi: 10.1212/01.wnl.0000203121.04509.31. Neurology. 2006. PMID: 16567708 Clinical Trial.

6

Natalizumab effects on immune cell responses in multiple sclerosis.

Niino M, Bodner C, Simard ML, Alatab S, Gano D, Kim HJ, Trigueiro M, Racicot D, Guérette C, Antel JP, Fournier A, Grand'Maison F, Bar-Or A. Niino M, et al. Ann Neurol. 2006 May;59(5):748-54. doi: 10.1002/ana.20859. Ann Neurol. 2006. PMID: 16634035 Clinical Trial.

7

Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.

Shapiro AM, Jack CS, Lapierre Y, Arbour N, Bar-Or A, Antel JP. Shapiro AM, et al. Arch Neurol. 2006 Sep;63(9):1296-9. doi: 10.1001/archneur.63.9.1296. Arch Neurol. 2006. PMID: 16966508

8

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A. Duddy M, et al. J Immunol. 2007 May 15;178(10):6092-9. doi: 10.4049/jimmunol.178.10.6092. J Immunol. 2007. PMID: 17475834

9

Experimental models of neuroprotection relevant to multiple sclerosis.

Yong VW, Giuliani F, Xue M, Bar-Or A, Metz LM. Yong VW, et al. Neurology. 2007 May 29;68(22 Suppl 3):S32-7; discussion S43-54. doi: 10.1212/01.wnl.0000275230.20635.72. Neurology. 2007. PMID: 17548566 Review.

10

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.

Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A. Banwell B, et al. Lancet Neurol. 2007 Sep;6(9):773-81. doi: 10.1016/S1474-4422(07)70196-5. Lancet Neurol. 2007. PMID: 17689148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page